Upstream Bio, Inc.
UPB
$5.85
-$0.34-5.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.16M | 3.32M | 2.85M | 2.80M | 2.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.16M | 3.32M | 2.85M | 2.80M | 2.72M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.16M | 3.32M | 2.85M | 2.80M | 2.72M |
| SG&A Expenses | 27.34M | 27.71M | 26.41M | 24.90M | 23.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.14M | 175.29M | 163.22M | 143.31M | 124.29M |
| Operating Income | -169.98M | -171.96M | -160.36M | -140.51M | -121.57M |
| Income Before Tax | -156.50M | -156.76M | -143.44M | -122.23M | -104.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -156.50 | -156.76 | -143.44 | -122.23 | -104.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -156.50M | -156.76M | -143.44M | -122.23M | -104.47M |
| EBIT | -169.98M | -171.96M | -160.36M | -140.51M | -121.57M |
| EBITDA | -169.78M | -171.77M | -160.17M | -140.33M | -121.42M |
| EPS Basic | -2.89 | -2.90 | -2.66 | -2.64 | -7.30 |
| Normalized Basic EPS | -1.80 | -1.81 | -1.66 | -1.46 | -4.38 |
| EPS Diluted | -2.89 | -2.90 | -2.66 | -2.64 | -7.30 |
| Normalized Diluted EPS | -1.80 | -1.81 | -1.66 | -1.46 | -4.38 |
| Average Basic Shares Outstanding | 216.92M | 216.12M | 215.41M | 207.02M | 156.11M |
| Average Diluted Shares Outstanding | 216.92M | 216.12M | 215.41M | 207.02M | 156.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |